Associate Professor, Medicine, Indiana University School of Medicine
Hematology
Dr. Paul R. Helft, MD
|
|
Give Review
Paul Helft practices Hematology. He attended University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine Paul Helft is a published physician. He has 72 papers published. The most current publication "O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterases." Dr. Paul R. Helft is registered with Medicare.
Publications
- Family caregiving challenges in advanced colorectal Cancer: patient and caregiver perspectives.
- CEASE: A Guide for Clinicians on How to Stop Resuscitation Efforts.
- Piloting an abbreviated dignity therapy intervention using a legacy-building web portal for adults with terminal Cancer: a feasibility and acceptability study.
- Reliability and validity of a tool to assess oncology nurses' experiences with prognosis-related communication.
- Phase 1 Pharmacogenetic and Pharmacodynamic Study of Sorafenib With Concurrent Radiation Therapy and Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer.
- Scope and outcomes of surrogate decision making among hospitalized older adults.
- A case of error disclosure: a communication privacy management Analysis.
- To transplant or not to transplant?
- Ethical considerations surrounding survival benefit-based Liver allocation.
- Pediatric CSI: Are Protons the Only Ethical Approach?
- Correlation between financial relationships with commercial interests and research prominence at an oncology meeting.
- Ethics in oncology: an annotated bibliography of important literature.
- Oncology nurses' experiences with prognosis-related communication with patients who have advanced Cancer.
- Reflections on my visit to a Chinese medical school--and an unplanned side trip to a Chinese hospital.
- Hard choices.
- Am I obligated to give therapy against my better judgment?
- To reduce futile care, build trust.
- What are my responsibilities to inform?
- Personalized medicine: medicine for the privileged?
- Communicating with clinicians: the experiences of surrogate decision-makers for hospitalized older adults.
- To keep them from injustice: reflections on the care of unauthorized immigrants with Cancer.
- Oncology Nurses' Narratives About Ethical Dilemmas and Prognosis-Related Communication in Advanced Cancer Patients.
- Contemporary Ethical Issues in Human Milk-Banking in the United States.
- A conceptual model of the role of communication in surrogate decision making for hospitalized adults.
- Oncology nurses' attitudes toward prognosis-related communication: a pilot mailed survey of oncology nursing society members.
- Timing of do-not-resuscitate orders for hospitalized older adults who require a surrogate decision-maker.
- The Patient-Doctor Relationship and Online Social Networks: Results of a National Survey.
- Medical decision-making during the guardianship process for incapacitated, hospitalized adults: a descriptive cohort study.
- Nurse ethicist: innovative resource for nurses.
- An evaluation of unit-based ethics conversations.
- The complexity of reproductive decisions for patients with advanced Cancer: ethical and communicative dimensions.
- Addressing Fertility in Patients With Advanced Cancer: How the Quality Oncology Practice Initiative Standards and ASCO Guidelines Facilitate Ethical Communication.
- Ethics education in surgical residency programs: a review of the literature.
- Facilitated ethics conversations: a novel program for managing mOral distress in bedside nursing staff.
- Hospice home nursing.
- The influence of psychosocial evaluation on candidacy for Liver transplantation.
- A new age for Cancer information seeking: are we better off now?
- Brain death revisited: the case for a national standard.
- Communication pitfalls with Cancer patients: "hit-and-run" deliveries of bad news.
- Cancer patients' attitudes toward future research uses of stored human biological materials.
- Metastatic esophageal carcinoma masquerading as inflammatory Breast carcinoma.
- Ethics, law, and commercial surrogacy: a call for uniformity.
- Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation.
- Long-term survival after excision of a solitary esophageal Cancer brain metastasis.
- An intimate collaboration: prognostic communication with advanced Cancer patients.
- Medical ethics education: where are we? Where should we be going? A review.
- Use of the internet to obtain Cancer information among Cancer patients at an urban county hospital.
- Necessary collusion: prognostic communication with advanced Cancer patients.
- A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid Tumors.
- Inside information: Financial conflicts of interest for research subjects in early phase clinical trials.
- American oncologists' views of internet use by Cancer patients: a mail survey of American Society of Clinical Oncology members.
- Making decisions for hospitalized older adults: ethical factors considered by family surrogates.
- End-of-Life Decisions and Off-Label Drug Use.
- Disclosing medical mistakes: a communication management plan for physicians.
- The rise and fall of the futility movement.
- O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterases.
- Associations among awareness of prognosis, hopefulness, and coping in patients with advanced Cancer participating in phase I clinical trials.
- A retrospective analysis of locally advanced esophageal Cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone.
- Breast Cancer in the information age: a review of recent developments.
- Cisplatin, fluorouracil, celecoxib, and RT in resectable esophageal Cancer: preliminary results.
- The ethics of CYP2D6 testing for patients considering tamoxifen.
- Oncology outpatient and provider responses to a computerized symptom assessment System.
- A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal Cancer.
- The do-not-resuscitate order: associations with advance directives, physician specialty and documentation of discussion 15 years after the Patient Self-Determination Act.
- In response to: Withdrawal of life-sustaining treatment in the first year of life.
- Takotsubo cardiomyopathy in a patient with esophageal Cancer: a case report.
- CT and radiation-related Cancer risk-time for a paradigm shift?
- Follow-up care delivery among colorectal Cancer survivors most often seen by primary and subspecialty care physicians.
- American society of clinical oncology statement: toward individualized care for patients with advanced Cancer.
- Long-term survival of a woman with well differentiated papillary mesothelioma of the peritoneum: a case report and review of the literature.
- A Phase II Study of Gemcitabine in Combination With Radiation Therapy in Patients With Localized, Unresectable, Pancreatic Cancer: A Hoosier Oncology Group Study.
Schools
University of Chicago
University Of Chicago Hosps
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
University of Chicago -
University of Chicago Pritzker School of Medicine
Drug Facts
| NPI NUMBER | 1417912387 | |
| NPPES Provider LastName | HELFT | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 462025116 | |
| NPPES Provider State | IN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 311.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 54.0 | |
| Percent Opioid Claims | 17.36 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417912387 |
| Last Name Of The Provider | HELFT |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Noah M. Hahn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jay A. Gaddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bryan P. Schneider, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naveen Manchanda, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Radhika V. Walling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Datchen F. Tai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elena G. Chiorean, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher A. Slapak, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Laurence H. Bates, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lindsay A. Schelling, MD |